---
title: "SNX13 and SNX14 maintain lysosome membrane integrity and limit cerebellar degeneration"
id: "medrxiv-14-snx13-and-snx14-interorganelle-tethers-suppress-lysosome-membrane-damage-and"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-14-snx13-and-snx14-interorganelle-tethers-suppress-lysosome-membrane-damage-and"
content_type: "clinical_feed_article"
specialty: "Neurology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.10.22.26365257v1?rss=1"
published_at: "2026-10-23T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# SNX13 and SNX14 maintain lysosome membrane integrity and limit cerebellar degeneration
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-14-snx13-and-snx14-interorganelle-tethers-suppress-lysosome-membrane-damage-and
- **Specialty:** [Neurology](https://medichelpline.com/clinical-feed/neurology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.10.22.26365257v1?rss=1)
- **Published At:** 2026-10-23T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The study identifies **SNX13** and **SNX14** as interorganelle tether proteins that preserve lysosomal membrane lipid composition and support repair after lysosome membrane permeabilization (LMP). - Investigators reported loss-of-function mutations in **SNX13** in children with a previously unrecognized cerebellar neurodegenerative disorder; the source linked these mutations to human disease but did not provide broader epidemiologic prevalence data. - The study team observed that Snx13 ablation in mice leads to Purkinje cell death and motor deficits described as ataxia-like; the preprint did not report specific behavioral test metrics in this abstract. - Data indicated loss of either **SNX13** or **SNX14** altered lysosome morphology, positioning, and acidity, and increased susceptibility to lysosome damage in cellular models. - Using lysosome immunoprecipitation and proteomics, authors mapped lysosome proteome remodeling during damage and repair and found that SNX13/14 deficiency blunted recruitment of repair machinery, including ESCRT complexes and PITT pathway proteins, to damaged lysosomes. - The cohort analysis and experimental work support a mechanism in which SNX13 and SNX14 act as lipid-binding proteins at ER–lysosome junctions, maintaining lysosomal phosphoinositide levels; the authors specifically noted impaired lysosome PtdIns4P signaling when either protein was lost. - Mechanistic data in the source link interorganelle lipid crosstalk by SNX13/14 to maintenance of lysosomal membrane competence for repair and suggest this mechanism is conserved across models examined. - The authors declared no competing interests and stated that clinical patient recruitment and consent were handled under IRB approvals at the listed institutions; the preprint did not report therapeutic interventions or clinical trial plans.
## Clinical Analysis & Structured Key Points
SNX13 and SNX14 interorganelle tethers suppress lysosome membrane damage and neurodegeneration | medRxiv Skip to main content SNX13 and SNX14 interorganelle tethers suppress lysosome membrane damage and neurodegeneration Kaitlynn Gov , Vanessa B Sanchez , Emma Reynolds , Caroline Bickerton , Teresa Jimenez , Sanghee Yun , Ipsita Chakraborty , Raunaq Deo , Daniel Smith , Thomas Roule , Blessy Paul , Sonakshi Srivastava , Amelia Eisch , Ophir Shalem , Xilma Ortiz-Gonzalez , Clementina Mesaros , Joseph G. Gleeson , Uner Tan , Antoine Pouzet , Caroline Nava , Brett Collins , William A. Prinz , Jeffrey McDonald , Jonathan Levy , Boris Keren , Alexandra Alfenjar , Joan Font-Burgada , W Mike Henne , Naiara Akizu doi: https://doi.org/10.64898/2026.10.22.26365257 Kaitlynn Gov 1 Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX, USA 75390; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Vanessa B Sanchez 2 Center for Brain Research in Development, Genetics and Engineering, Children's Hospital of Philadelphia, PA, USA; Perelman Center for Cellular and Molecular Therapeutics, Children's Hospital of Philadelphia, Philadelphia, PA, USA; Department of Pathology; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Emma Reynolds 1 Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX, USA 75390; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Caroline Bickerton 2 Center for Brain Research in Development, Genetics and Engineering, Children's Hospital of Philadelphia, PA, USA; Perelman Center for Cellular and Molecular Therapeutics, Children's Hospital of Philadelphia, Philadelphia, PA, USA; Department of Pathology; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Teresa Jimenez 2 Center for Brain Research in Development, Genetics and Engineering, Children's Hospital of Philadelphia, PA, USA; Perelman Center for Cellular and Molecular Therapeutics, Children's Hospital of Philadelphia, Philadelphia, PA, USA; Department of Pathology; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Sanghee Yun 3 Center for Brain Research in Development, Genetics and Engineering, Children's Hospital of Philadelphia, PA, USA; Department of Anesthesiology and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department o; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Ipsita Chakraborty 1 Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX, USA 75390; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Raunaq Deo 1 Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX, USA 75390; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Daniel Smith 4 Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX, USA, 75390; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Thomas Roule 2 Center for Brain Research in Development, Genetics and Engineering, Children's Hospital of Philadelphia, PA, USA; Perelman Center for Cellular and Molecular Therapeutics, Children's Hospital of Philadelphia, Philadelphia, PA, USA; Department of Pathology; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Blessy Paul 5 Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX, USA 75390; Present address: Texas Tech University Health Science Sciences Center, Dallas, Texas, 75390; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Sonakshi Srivastava 1 Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX, USA 75390; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Amelia Eisch 3 Center for Brain Research in Development, Genetics and Engineering, Children's Hospital of Philadelphia, PA, USA; Department of Anesthesiology and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department o; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Ophir Shalem 6 Perelman Center for Cellular and Molecular Therapeutics, Children's Hospital of Philadelphia, Philadelphia, PA, USA; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Xilma Ortiz-Gonzalez 7 Center for Brain Research in Development, Genetics and Engineering, Children's Hospital of Philadelphia, PA, USA; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Clementina Mesaros 8 Department of Systems Pharmacology and Translational Therapeutics and Biomolecular Mass Spectrometry Core, Center of Excellence in Environmental Toxicology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Joseph G. Gleeson 9 Department of Neurosciences, University of California San Diego, La Jolla, and Rady Children's Institute for Genomic Medicine, San Diego, CA, USA.; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Uner Tan 10 Department of Physiology, Faculty of Medicine, Cukurova University, Adana, Turkey.; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Antoine Pouzet 11 Service de Cytogenomique, Hopital Robert-Debre, Assistance Publique Hopitaux de Paris (AP-HP), Paris, France; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Caroline Nava 12 Departement de genetique medicale, Hopital Pitie Salpetriere, Assistance Publique Hopitaux de Paris. Sorbonne Universite, Paris, France.; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Brett Collins 13 Institute for Molecular Bioscience, University of Queensland, Queensland, Australia; Find this author on Google Scholar Find this author on PubMed Search for this author on this site William A. Prinz 1 Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX, USA 75390; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Jeffrey McDonald 4 Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX, USA, 75390; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Jonathan Levy 11 Service de Cytogenomique, Hopital Robert-Debre, Assistance Publique Hopitaux de Paris (AP-HP), Paris, France; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Boris Keren 12 Departement de genetique medicale, Hopital Pitie Salpetriere, Assistance Publique Hopitaux de Paris. Sorbonne Universite, Paris, France.; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Alexandra Alfenjar 14 Centre de reference des malformations et maladies congenitales du cervelet, UF de genetique clinique, Sorbonne Universite, GRC n19, pathologies Congenitales du Cervelet LeucoDystrophies, Assistance Publique Hopitaux de Paris, Hopital Armand Trousseau, F75; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Joan Font-Burgada 15 Cancer Signaling and Microenvironment Program, Fox Chase Cancer Center, Philadelphia, PA, USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site W Mike Henne 1 Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX, USA 75390; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Naiara Akizu 2 Center for Brain Research in Development, Genetics and Engineering, Children's Hospital of Philadelphia, PA, USA; Perelman Center for Cellular and Molecular Therapeutics, Children's Hospital of Philadelphia, Philadelphia, PA, USA; Department of Pathology; Find this author on Google Scholar Find this author on PubMed Search for this author on this site For correspondence: aquizun{at}chop.edu Abstract Info/History Metrics Data/Code Preview PDF Abstract Lysosome membrane permeabilization (LMP) is an emerging signature of neurodegenerative diseases, yet the mechanisms that enable an effective repair are largely undefined, particularly in neurons. Here, we reveal sorting nexin (SNX) proteins SNX13 and SNX14 maintain lysosome membrane lipid composition to support efficient LMP repair and neuronal survival. We identify loss of function mutations in SNX13 in children manifesting a previously unrecognized cerebellar neurodegenerative disorder. Consistently, Snx13 ablation in mice causes cerebellar Purkinje cell death and signatures of ataxia-like motor deficits. We show loss of SNX13 or its ataxia-linked paralog SNX14 perturbs lysosome morphology, positioning, and acidity and causes increased susceptibility to lysosome damage. Using lysosome immunoprecipitation and proteomics, we comprehensively map lysosome proteome remodeling during membrane damage and repair, finding that SNX13 or SNX14 deficiency blunts recruitment of repair machinery, including ESCRTs and PITT pathway proteins, to damaged lysosomes. Mechanistically, we determine SNX13 and SNX14 support lysosome integrity through interorganelle lipid crosstalk. We define SNX13 and SNX14 as lipid binding proteins that localize to ER-lysosome junctions, where they support lysosomal phosphoinositide levels in response to membrane damage. In line with this, loss of SNX13 or SNX14 impairs lysosome PtdIns4P signaling. Altogether, our work reveals a conserved mechanism of interorganelle lipid crosstalk by SNX13/14 family proteins that safeguards lysosome membranes, maintaining them competent for repair, and is defective in cerebellar neurodegeneration. Competing Interest Statement The authors have declared no competing interest. Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: Patients included in this study were identified by connections through GeneMatcher80 and national and international collaborations. Patient recruitment and participation were covered by Institutional Review Board approvals at the respective institutions, including Hopital Robert-Debre, Hopital Pitie-Salpetriere, and University of California San Diego. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability All data produced in the present study are available upon reasonable request to the authors Funder Information Declared National Institute of Diabetes and Digestive and Kidney Diseases, https://ror.org/00adh9b73 , R01DK126887 National Institute of General Medical Sciences , R35GM119768 , T32GM153602-02 , R35GM153315. Ara Parseghian Medical Research Fund, https://ror.org/02ps3ca75 National Institute of Neurological Disorders and Stroke, https://ror.org/01s5ya894 , F31NS130942 , T32NS007413 , R01NS119699 National Institute of Mental Health, https://ror.org/04xeg9z08 , R01MH129970 National Ataxia Foundation, https://ror.org/03s9xxw55 ARC Discovery , 230100552 Eagles autism foundation NHMRC Investigator Grant , 2016410 Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Back to top Previous Next Posted October 23, 2026. Download PDF Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following SNX13 and SNX14 interorganelle tethers suppress lysosome membrane damage and neurodegeneration Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share SNX13 and SNX14 interorganelle tethers suppress lysosome membrane damage and neurodegeneration Kaitlynn Gov , Vanessa B Sanchez , Emma Reynolds , Caroline Bickerton , Teresa Jimenez , Sanghee Yun , Ipsita Chakraborty , Raunaq Deo , Daniel Smith , Thomas Roule , Blessy Paul , Sonakshi Srivastava , Amelia Eisch , Ophir Shalem , Xilma Ortiz-Gonzalez , Clementina Mesaros , Joseph G. Gleeson , Uner Tan , Antoine Pouzet , Caroline Nava , Brett Collins , William A. Prinz , Jeffrey McDonald , Jonathan Levy , Boris Keren , Alexandra Alfenjar , Joan Font-Burgada , W Mike Henne , Naiara Akizu medRxiv 2026.10.22.26365257; doi: https://doi.org/10.64898/2026.10.22.26365257 Share This Article: Copy Citation Tools SNX13 and SNX14 interorganelle tethers suppress lysosome membrane damage and neurodegeneration Kaitlynn Gov , Vanessa B Sanchez , Emma Reynolds , Caroline Bickerton , Teresa Jimenez , Sanghee Yun , Ipsita Chakraborty , Raunaq Deo , Daniel Smith , Thomas Roule , Blessy Paul , Sonakshi Srivastava , Amelia Eisch , Ophir Shalem , Xilma Ortiz-Gonzalez , Clementina Mesaros , Joseph G. Gleeson , Uner Tan , Antoine Pouzet , Caroline Nava , Brett Collins , William A. Prinz , Jeffrey McDonald , Jonathan Levy , Boris Keren , Alexandra Alfenjar , Joan Font-Burgada , W Mike Henne , Naiara Akizu medRxiv 2026.10.22.26365257; doi: https://doi.org/10.64898/2026.10.22.26365257 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Areas All Articles Addiction Medicine (634) Allergy and Immunology (914) Anesthesia (346) Cardiovascular Medicine (4943) Dentistry and Oral Medicine (490) Dermatology (425) Emergency Medicine (672) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1667) Epidemiology (16164) Forensic Medicine (35) Gastroenterology (1236) Genetic and Genomic Medicine (7213) Geriatric Medicine (747) Health Economics (1091) Health Informatics (5222) Health Policy (1456) Health Systems and Quality Improvement (1812) Hematology (597) HIV/AIDS (1370) Infectious Diseases (except HIV/AIDS) (16427) Intensive Care and Critical Care Medicine (1192) Medical Education (690) Medical Ethics (156) Nephrology (739) Neurology (7499) Nursing (375) Nutrition (1114) Obstetrics and Gynecology (1281) Occupational and Environmental Health (1031) Oncology (3708) Ophthalmology (1079) Orthopedics (401) Otolaryngology (462) Pain Medicine (493) Palliative Medicine (142) Pathology (717) Pediatrics (1844) Pharmacology and Therapeutics (749) Primary Care Research (781) Psychiatry and Clinical Psychology (6065) Public and Global Health (9915) Radiology and Imaging (2499) Rehabilitation Medicine and Physical Therapy (1500) Respiratory Medicine (1263) Rheumatology (655) Sexual and Reproductive Health (794) Sports Medicine (594) Surgery (795) Toxicology (109) Transplantation (315) Urology (303)
## Related Clinical Research

- [Altered scaling and timing of cortical N1 responses during reactive balance after stroke](https://medichelpline.com/clinical-feed/medrxiv-8-greater-scaling-and-less-flexible-timing-of-cortical-responses-during.md)
- [APOLLAI AI versus EMS for prehospital detection of stroke deficits](https://medichelpline.com/clinical-feed/medrxiv-0-apollai-a-multimodal-ai-system-versus-ems-personnel-for-prehospital-detection.md)
- [Rising national stroke incidence and deaths in Uganda, 2016–2028 forecasts](https://medichelpline.com/clinical-feed/plos-one-5-rising-stroke-burden-in-uganda-a-national-time-series-analysis-and-forecasts.md)
- [Pre-stroke Social Participation and Physical Resilience After Stroke Across Frailty Levels](https://medichelpline.com/clinical-feed/plos-one-15-association-between-pre-stroke-social-participation-and-current-physical.md)
- [Ultra-processed foods linked to MRI signs of vascular brain injury in middle-aged adults](https://medichelpline.com/clinical-feed/medical-news-today-0-ultra-processed-foods-may-be-harming-brain-health-in-otherwise-healthy-adults.md)

## Navigation
- [← Back to Neurology Feed](https://medichelpline.com/clinical-feed/neurology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.